In last trading session, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) saw 1.11 million shares changing hands with its beta currently measuring 2.82. Company’s recent per share price level of $1.51 trading at -$0.13 or -7.93% at ring of the bell on the day assigns it a market valuation of $2.23M. That closing price of SXTP’s stock is at a discount of -2283.44% from its 52-week high price of $35.99 and is indicating a premium of 6.62% from its 52-week low price of $1.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 631.62K if we extend that period to 3-months.
For 60 Degrees Pharmaceuticals Inc (SXTP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
60 Degrees Pharmaceuticals Inc’s shares saw a change of -89.04% in year-to-date performance and have moved -42.15% in past 5-day. 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) showed a performance of -30.09% in past 30-days. Number of shares sold short was 37468.0 shares which calculate 0.15 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.29% during past 5 years.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
Insiders are in possession of 4.97% of company’s total shares while institution are holding 7.30 percent of that, with stock having share float percentage of 7.68%. Investors also watch the number of corporate investors in a company very closely, which is 7.30% institutions for 60 Degrees Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 9.6 shares of worth $14489.0 or 0.65% of the total outstanding shares. The later fund manager was in possession of 2.24 shares on May 31, 2025 , making its stake of worth around $3376.0 in the company or a holder of 0.15% of company’s stock.
